Telesis Bio, Inc.
MESSENGER RNA THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA
Last updated:
Abstract:
The present invention provides methods and compositions of treating Friedreich's ataxia (FRDA) based on administering an mRNA encoding a frataxin protein.
Status:
Application
Type:
Utility
Filling date:
10 Sep 2020
Issue date:
24 Jun 2021